Focus our drug development programs to directly target unmet medical needs. Focus our drug development programs to directly target the drivers of disease progression.
Every payment is processed via Razorpay with PCI-DSS data protection and SSL encryption. We never see your card details.
PayUPIVisaMCAmexRuPayNet BankingWalletsPay Later+ more
Money-back protection
Claim a refund if your order doesn't ship, arrives damaged, or doesn't match the agreed spec. Disputes resolved within 7 working days.
Trade Assurance — not yet enrolled by this seller
This seller has not yet activated Trade Assurance. Pay outside BharatSeal at your own risk — we recommend chatting first to verify.
Only orders placed and paid through BharatSeal can enjoy free protection by 🛡 BharatSeal Trade Assurance.
Highlights at a glance
✓Category: Therapeutics
✓Made in Bangalore, KA, India
About this item
Enzymatically inactivates sialic acid receptors used by influenza A and B viruses
Targets parainfluenza viruses and additional viruses causing respiratory infection
Undergoing Phase 3 clinical trial for treatment of PIV in immunocompromised patients
Description
DAS181, a fusion protein with an active sialidase domain that enzymatically inactivates sialic acid receptors used by all influenza A and B viruses, parainfluenza viruses, and additional viruses which cause respiratory infection.
Key attributes
Category
Therapeutics
Place of origin
Bangalore, KA, India
Reviews
Questions & answers
Ask the supplier — answers are visible to all buyers